Ratings by Jefferies (Amy Li)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/11/2026 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2026 | Scholar Rock | SRRK | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2026 | Biohaven Pharma | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2026 | Ironwood Pharmaceuticals | IRWD | Maintain | Hold (N/A) |
|
Details | ||
| 1/13/2026 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2025 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2025 | Scholar Rock | SRRK | New Coverage | Buy (N/A) |
30.12 (51.43) |
70.75% | Details | |
| 8/15/2025 | Liquidia Technologies | LQDA | New Coverage | Buy (N/A) |
26.09 (75.86) |
190.76% | Details | |
| 4/15/2025 | Ironwood Pharmaceuticals | IRWD | Downgrade | Hold (Buy) |
0.95 (3.86) |
306.32% | Details | |
| 3/5/2025 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2024 | Biohaven Pharmaceutical Holding | BHVN | New Coverage | Buy (N/A) |
38.08 (15.40) |
-59.56% | Details | |
| 3/1/2024 | Ironwood Pharmaceuticals | IRWD | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | Ironwood Pharmaceuticals | IRWD | New Coverage | Buy (N/A) |
9.23 (0.95) |
-89.71% | Details |
